A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome.
Kim ER, Park JS, Kim JH, Oh JY, Oh IJ, Choi DH, Lee YS, Park IS, Kim S, Lee DH, Cheon JH, Bae JW, Lee M, Cho JW, An IB, Nam EJ, Yang SI, Lee MS, Bae SH, Lee YH.
Kim ER, et al. Among authors: an ib.
Hepatology. 2022 Jun;75(6):1523-1538. doi: 10.1002/hep.32235. Epub 2021 Dec 18.
Hepatology. 2022.
PMID: 34773257